Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.4% |
| 2 | Technology | 18.51% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Financials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JXG
3526
JX Luxventure
JXG
$85.5M
| $123K | ﹤0.01% |
236
+2
| +0.9% | +$1.43K |
|
|
GTH
3527
DELISTED
Genetron Holdings Limited ADS
GTH
| $123K | ﹤0.01% |
52,333
+1,243
| +2% | +$4.18K |
|
|
FATH
3528
DELISTED
Fathom Digital Manufacturing Corporation
FATH
| $123K | ﹤0.01% |
+3,020
| New | +$207K |
|
3529
Destination XL Group
DXLG
$30.7M
| $122K | ﹤0.01% |
+22,600
| New | +$108K |
|
3530
Phio Pharmaceuticals
PHIO
$12.4M
| $122K | ﹤0.01% |
1,978
-197
| -9% | -$14.9K |
|
3531
Protalix BioTherapeutics
PLX
$197M
| $122K | ﹤0.01% |
117,200
+2,400
| +2% | +$2.66K |
|
3532
ReTo Eco-Solutions
RETO
| $121K | ﹤0.01% |
1
-1
| -50% | -$128K |
|
3533
United States Antimony
UAMY
$945M
| $121K | ﹤0.01% |
329,099
-115,796
| -26% | -$50.4K |
|
3534
Evotec
EVO
$704M
| $120K | ﹤0.01% |
+13,699
| New | +$163K |
|
3535
TMC The Metals Company
TMC
$1.74B
| $120K | ﹤0.01% |
114,000
+73,800
| +184% | +$71.2K |
|
3536
Axogen
AXGN
$2.43B
| $119K | ﹤0.01% |
10,000
-11,700
| -54% | -$117K |
|
|
NVIV
3537
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $119K | ﹤0.01% |
+27,725
| New | +$152K |
|
3538
Research Solutions
RSSS
$73.9M
| $118K | ﹤0.01% |
57,700
+9,300
| +19% | +$17.3K |
|
3539
Arts-Way Manufacturing Co
ARTW
$11.5M
| $117K | ﹤0.01% |
64,003
+8,729
| +16% | +$19.3K |
|
|
DAO
3540
Youdao
DAO
$2.08B
| $117K | ﹤0.01% |
29,700
+4,100
| +16% | +$19.9K |
|
|
HEPA
3541
DELISTED
Hepion Pharmaceuticals
HEPA
| $117K | ﹤0.01% |
232
-3
| -1% | -$1.83K |
|
|
JG
3542
Aurora Mobile
JG
$29.3M
| $117K | ﹤0.01% |
5,905
-110
| -2% | -$2.08K |
|
|
TSP
3543
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $116K | ﹤0.01% |
15,300
-759,000
| -98% | -$6.35M |
|
|
SOL
3544
DELISTED
Emeren Group
SOL
| $115K | ﹤0.01% |
22,900
-54,900
| -71% | -$313K |
|
|
USER
3545
DELISTED
UserTesting, Inc.
USER
| $115K | ﹤0.01% |
+29,307
| New | +$144K |
|
3546
Boxlight
BOXL
$2.05M
| $114K | ﹤0.01% |
128
+22
| +21% | +$20.5K |
|
3547
Jaguar Health
JAGX
$5.16M
| – | – |
0
| – | – |
|
3548
Spire Global
SPIR
$499M
| $114K | ﹤0.01% |
13,145
-52,813
| -80% | -$573K |
|
|
MAAS
3549
Maase Inc
MAAS
$8.17B
| $114K | ﹤0.01% |
259
-38
| -13% | -$18.3K |
|
|
NBSE
3550
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $114K | ﹤0.01% |
14,369
+2,412
| +20% | +$39.9K |
|
Similar funds
Renaissance Technologies's Q3 2022 Portfolio in Review
As of Q3 2022, Renaissance Technologies held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class A worth $498M.
- Renaissance Technologies's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Renaissance Technologies added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Renaissance Technologies's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Renaissance Technologies fully exited Shopify in Q3 2022, selling an estimated $439M.
- Renaissance Technologies's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Renaissance Technologies opened 440 new positions and closed 637 in Q3 2022.
- Renaissance Technologies's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.